|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,378.00 DKK | -1.18% |
|
+6.12% | -7.67% |
| 11/07 | Baptista Research Begins Genmab Coverage at Outperform | MT |
| 01/07 | Genmab Announces Changes to Its Executive Committee | CI |
Main competitors
| Fundamentals (Composite) | Global Valuation (Composite) | Consensus (Composite) | Financial estimates revisions (Composite) | Visibility (Composite) | Investor (Composite) | ESG MSCI | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
AA | 1.33TCr | ||||||||
AA | 3.44TCr | ||||||||
AAA | 3.08TCr | ||||||||
AAA | 1.38TCr | ||||||||
B | 1.29TCr | ||||||||
BB | 1.22TCr | ||||||||
A | 611.2Cr | ||||||||
| - | - | 595.16Cr | |||||||
BB | 581.97Cr | ||||||||
| Average | A | 1.5TCr | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition